InsiderClue
Stocks · Health care · Orthopedic, Prosthetic & Surgical Appliances & Supplies

MYOMO, INC.

MYO Clue Score59
United States Fiscal year ends December CIK 0001369290 Results filed 5 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

73
Insider
Date
Role
Action
Shares
Price
Amount
Harry Kovelman
11 Sep 2026
Chief Medical Officer
Sell
15,488
$1.27
$19.68K
Milton Mayo Morris
2 Sep 2026
Director
Sell
15,000
$1.41
$21.15K
Harry Kovelman
20 Aug 2026
Chief Medical Officer
Sell
17,250
$1.73
$29.90K
Thomas F Kirk
5 Jun 2026
Director
Buy
40,002
$1.27
$50.80K
Harry Kovelman
28 May 2026
Chief Medical Officer
Sell
11,536
$1.02
$11.73K
Thomas F Kirk
28 May 2026
Director
Buy
25,000
$0.99
$24.83K
Harry Kovelman
27 May 2026
Chief Medical Officer
Sell
20,464
$1.00
$20.50K
Thomas F Kirk
18 May 2026
Director
Buy
43,401
$0.91
$39.49K
Joseph M. Manko Jr.
15 May 2026
Director
Buy indirect
30,367
$0.89
$26.96K
Thomas F Kirk
15 May 2026
Director
Buy
31,605
$0.91
$28.75K
Joseph M. Manko Jr.
14 May 2026
Director
Buy indirect
170,830
$0.86
$146.95K
Heather C Getz
16 Mar 2026
Director
Buy
20,000
$0.70
$13.97K
Thomas F Kirk
13 Mar 2026
Director
Buy
72,000
$0.71
$51.11K
Heather C Getz
12 Mar 2026
Director
Buy
70,000
$0.73
$50.96K
Thomas F Kirk
21 Nov 2025
Director
Buy
2,535
$0.72
$1.83K
Thomas F Kirk
20 Nov 2025
Director
Buy
4,902
$0.72
$3.53K
Thomas Aloysius Crowley Jr.
19 Nov 2025
Director
Buy indirect
385
$0.77
$294.53
Thomas Aloysius Crowley Jr.
18 Nov 2025
Director
Buy
4,000
$0.73
$2.94K
Thomas F Kirk
25 Aug 2025
Director
Buy
50,000
$1.15
$57.50K
Thomas F Kirk
18 Aug 2025
Director
Buy
50,000
$1.10
$55.00K
Paul R Gudonis
15 Aug 2025
Chief Executive Officer
Buy
50,000
$0.95
$47.30K
Paul R Gudonis
15 May 2025
Chief Executive Officer
Buy
30,000
$3.22
$96.61K
Thomas F Kirk
15 May 2025
Director
Buy
36,824
$3.25
$119.68K
Thomas F Kirk
14 May 2025
Director
Buy
1,943
$3.25
$6.31K
Micah Mitchell
14 May 2025
Chief Commercial Officer
Sell
90,231
$0.86
$77.69K
Thomas F Kirk
12 May 2025
Director
Buy
50,000
$3.35
$167.50K
Micah Mitchell
14 Mar 2025
Chief Commercial Officer
Sell
48,000
$5.16
$247.56K
Thomas F Kirk
13 Mar 2025
Director
Buy
7,400
$5.00
$37.00K
Harry Kovelman
12 Mar 2025
Chief Medical Officer
Sell
30,000
$5.50
$165.02K
Paul R Gudonis
13 Feb 2025
Chief Executive Officer
Exercised, kept
694
$0.05
$33.31
Harry Kovelman
5 Sep 2024
Chief Medical Officer
Sell
6,700
$3.76
$25.18K
Harry Kovelman
3 Sep 2024
Chief Medical Officer
Sell
2,029
$4.01
$8.14K
Thomas F Kirk
29 May 2024
Director
Buy
50,000
$3.50
$175.00K
Harry Kovelman
15 May 2024
Chief Medical Officer
Sell
35,426
$3.69
$130.84K
Thomas F Kirk
14 Mar 2024
Director
Buy
50,000
$3.50
$175.00K
Thomas Aloysius Crowley Jr.
8 Dec 2023
Director
Sell
14,997
—
no price
Harry Kovelman
1 Dec 2023
Chief Medical Officer
Sold on a plan
8,333
—
no price
Thomas Aloysius Crowley Jr.
28 Nov 2023
Director
Sell
14,997
—
no price
Thomas F Kirk
20 Nov 2023
Director
Buy
50,000
$3.10
$155.00K
Milton Mayo Morris
8 Sep 2023
Director
Buy
15,000
$1.06
$15.87K
Paul R Gudonis
30 Aug 2023
Chief Executive Officer
Buy
48,400
$0.74
$36.04K
Paul R Gudonis
29 Aug 2023
Chief Executive Officer
Buy
37,000
$0.78
$28.80K
David A Henry
29 Aug 2023
Chief Financial Officer
Buy
41,666
$0.60
$25.00K
Harry Kovelman
29 Aug 2023
Chief Medical Officer
Buy
8,333
$0.60
$5.00K
Paul R Gudonis
28 Aug 2023
Chief Executive Officer
Buy
42,500
$0.75
$31.79K
Paul R Gudonis
17 Jan 2023
Chief Executive Officer
Buy
307,692
$0.33
$100.00K
David A Henry
17 Jan 2023
Chief Financial Officer
Buy
76,923
$0.33
$25.00K
Micah Mitchell
17 Jan 2023
Chief Commerical Officer
Buy
15,384
$0.33
$5.00K
Thomas F Kirk
1 Dec 2022
Director
Exercised, kept
333
$0.00
$0.03
David A Henry
22 Nov 2022
Chief Financial Officer
Buy
9,000
$0.55
$4.96K
Paul R Gudonis
21 Nov 2022
Chief Executive Officer
Exercised, kept
333
$0.00
$0.03
Thomas Aloysius Crowley Jr.
5 Aug 2022
Director
Sell
7,141
$1.71
$12.22K
Thomas Aloysius Crowley Jr.
14 Jun 2022
Director
Sell
291
$1.67
$485.39
Thomas Aloysius Crowley Jr.
10 Jun 2022
Director
Sell
6,000
$1.97
$11.79K
Thomas Aloysius Crowley Jr.
9 Jun 2022
Director
Sell
110
$2.15
$236.06
Thomas Aloysius Crowley Jr.
8 Jun 2022
Director
Sell
3,000
$2.15
$6.44K
Thomas Aloysius Crowley Jr.
6 Jun 2022
Director
Sell
3,500
$2.29
$8.00K
Paul R Gudonis
14 Mar 2022
Chief Executive Officer
Buy
5,000
$4.22
$21.09K
Paul R Gudonis
11 Mar 2022
Chief Executive Officer
Buy
5,000
$4.63
$23.15K
David A Henry
16 Nov 2021
Chief Financial Officer
Buy
1,000
$8.86
$8.86K
Paul R Gudonis
12 Nov 2021
Chief Executive Officer
Buy
1,000
$9.86
$9.86K
Thomas Aloysius Crowley Jr.
2 Nov 2021
Director
Exercised, kept
208
$0.05
$9.98
Thomas Aloysius Crowley Jr.
2 Nov 2021
Director
Exercised, kept
211
$0.05
$10.13
Micah Mitchell
21 Jul 2021
Chief Commerical Officer
Sell
1,385
—
no price
Micah Mitchell
20 Jul 2021
Chief Commerical Officer
Sell
5,745
—
no price
Thomas Aloysius Crowley Jr.
10 Jun 2021
Director
Exercised, kept
419
$0.05
$20.11
David A Henry
13 Feb 2020
Chief Financial Officer
Buy
3,500
$6.99
$24.47K
Paul R Gudonis
13 Feb 2020
Chief Executive Officer
Buy
6,000
$6.99
$41.94K
Thomas F Kirk
13 Feb 2020
Director
Buy
3,500
$6.99
$24.47K
Thomas F Kirk
9 Jun 2017
Director
Buy
20,000
—
no price
Jonathan Naft
9 Jun 2017
VP, General Manager
Buy
10,000
—
no price
Paul R Gudonis
9 Jun 2017
Chief Executive Officer
Buy
14,000
—
no price
Steve Sanghi
9 Jun 2017
Director
Buy
95,238
—
no price

What was left out

Form 4 filings counted 251
Amendments (4/A) skipped 18
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 0
Sales at will 21
Transactions with no price 9
Shares from compensation/vesting 5,325,903
Sales filed before the plan box existed 3
History held since 13 Jun 2017